Interviews with participating patients from the VenoValve® U.S. Pivotal TrialWebcast replay from with the presenting Primary ...

Consultant vascular surgeon Ian Nichol, who works at The James Cook University Hospital, saved the leg of Chris Dolan, 50 ...

A doctor advises that several foot issues may signal an underlying health condition, but having symptoms doesn't necessarily ...

A new federal payment policy will sharply reduce the number of specialty wound care products available to certain Medicare patients.

Clinical Meaningful Benefit Responder Rate7.91 Point Average rVCSS Improvement for the Clinically Meaningful Benefit Responder Cohort75% ...

BioStem expects to finalize definitive agreements within 60 days following customary due diligence. The transaction is subject to regulatory approvals and Board consent. BioStem and ProgenaCare will ...

The Company is also developing a next-generation, non-surgical transcatheter based replacement venous valve called enVVe, which could appeal to an even larger market in terms of both patients and ...

Medical products group Convatec has expressed disappointment with a ruling which excludes its InnovaMatrix product from ...

Report with market evolution powered by AI - The global wound care market size is estimated to grow by USD 6.95 billion from ...

Kerecis, the pioneer in the use of fish skin and fatty acids for tissue regeneration and protection, today announced Medicare ...